Ataxia

Ataxia
Classification and external resources
Specialty Neurology
ICD-10 R27.0
DiseasesDB 15409
MeSH D001259

Ataxia is a neurological sign consisting of lack of voluntary coordination of muscle movements that includes gait abnormality. Ataxia is a non-specific clinical manifestation implying dysfunction of the parts of the nervous system that coordinate movement, such as the cerebellum. Ataxia can be limited to one side of the body, which is referred to as hemiataxia. Several possible causes exist for these patterns of neurological dysfunction. Dystaxia is a mild degree of ataxia. Friedreich's ataxia has gait abnormality as the most commonly presented symptom.[1] The word is from Greek α- [a negative prefix] + -τάξις [order] = "lack of order".

Types

Cerebellar

The term cerebellar ataxia is used to indicate ataxia that is due to dysfunction of the cerebellum. The cerebellum is responsible for integrating a significant amount of neural information that is used to coordinate smoothly ongoing movements and to participate in motor planning. Although ataxia is not present with all cerebellar lesions, many conditions affecting the cerebellum do produce ataxia.[2] People with cerebellar ataxia may have trouble regulating the force, range, direction, velocity and rhythm of muscle contractions.[3] This results in a characteristic type of irregular, uncoordinated movement that can manifest itself in many possible ways, such as asthenia, asynergy, delayed reaction time, and dyschronometria. Individuals with cerebellar ataxia could also display instability of gait, difficulty with eye movements, dysarthria, dysphagia, hypotonia, dysmetria and dysdiadochokinesia.[2] These deficits can vary depending on which cerebellar structures have been damaged, and whether the lesion is bilateral or unilateral.

People with cerebellar ataxia may initially present with poor balance, which could be demonstrated as an inability to stand on one leg or perform tandem gait. As the condition progresses, walking is characterized by a widened base and high stepping, as well as staggering and lurching from side to side.[2] Turning is also problematic and could result in falls. As cerebellar ataxia becomes severe, great assistance and effort are needed to stand and walk.[2] Dysarthria, an impairment with articulation, may also be present and is characterized by "scanning" speech that consists of slower rate, irregular rhythm and variable volume.[2] There may also be slurring of speech, tremor of the voice and ataxic respiration. Cerebellar ataxia could result with incoordination of movement, particularly in the extremities. There is overshooting (or hypermetria) with finger to nose testing, and heel to shin testing; thus, dysmetria is evident.[2][4] Impairments with alternating movements (dysdiadochokinesia), as well as dysrhythmia, may also be displayed. There may also be tremor of the head and trunk (titubation) in individuals with cerebellar ataxia.[2]

It is thought that dysmetria is caused by a deficit in the control of interaction torques in multijoint motion.[5] Interaction torques are created at an associated joint when the primary joint is moved. For example, if a movement required reaching to touch a target in front of the body, flexion at the shoulder would create a torque at the elbow, while extension of the elbow would create a torque at the wrist. These torques increase as the speed of movement increases and must be compensated and adjusted for to create coordinated movement. This may, therefore, explain decreased coordination at higher movement velocities and accelerations.

Sensory

The term sensory ataxia is employed to indicate ataxia due to loss of proprioception, the loss of sensitivity to the positions of joint and body parts. This is generally caused by dysfunction of the dorsal columns of the spinal cord, because they carry proprioceptive information up to the brain. In some cases, the cause of sensory ataxia may instead be dysfunction of the various parts of the brain which receive positional information, including the cerebellum, thalamus, and parietal lobes.

Sensory ataxia presents itself with an unsteady "stomping" gait with heavy heel strikes, as well as a postural instability that is usually worsened when the lack of proprioceptive input cannot be compensated for by visual input, such as in poorly lit environments.

Physicians can find evidence of sensory ataxia during physical examination by having the patient stand with his/her feet together and eyes shut. In affected patients, this will cause the instability to worsen markedly, producing wide oscillations and possibly a fall. This is called a positive Romberg's test. Worsening of the finger-pointing test with the eyes closed is another feature of sensory ataxia. Also, when the patient is standing with arms and hands extended toward the physician, if the eyes are closed, the patient's finger will tend to "fall down" and then be restored to the horizontal extended position by sudden muscular contractions (the "ataxic hand").

Vestibular

The term vestibular ataxia is employed to indicate ataxia due to dysfunction of the vestibular system, which in acute and unilateral cases is associated with prominent vertigo, nausea and vomiting. In slow-onset, chronic bilateral cases of vestibular dysfunction, these characteristic manifestations may be absent, and dysequilibrium may be the sole presentation.

Causes

The three types of ataxia have overlapping causes, and therefore can either coexist or occur in isolation.

Focal lesions

Any type of focal lesion of the central nervous system (such as stroke, brain tumor, multiple sclerosis) will cause the type of ataxia corresponding to the site of the lesion: cerebellar if in the cerebellum, sensory if in the dorsal spinal cord (and rarely in the thalamus or parietal lobe), vestibular if in the vestibular system (including the vestibular areas of the cerebral cortex).

Exogenous substances (metabolic ataxia)

Exogenous substances that cause ataxia mainly do so because they have a depressant effect on central nervous system function. The most common example is ethanol (alcohol), which is capable of causing reversible cerebellar and vestibular ataxia. Other examples include various prescription drugs (e.g. most antiepileptic drugs have cerebellar ataxia as a possible adverse effect), Lithium level over 1.5mEq/L, synthetic cannabinoid HU-211 ingestion[11] and various other recreational drugs (e.g. ketamine, PCP or dextromethorphan, all of which are NMDA receptor antagonists that produce a dissociative state at high doses). A further class of pharmaceuticals which can cause short term ataxia, especially in high doses are the benzodiazepines.[12][13] Exposure to high levels of methylmercury, through consumption of fish with high mercury concentrations, is also a known cause of ataxia and other neurological disorders.[14]

Radiation poisoning

Ataxia can be induced as a result of severe acute radiation poisoning with an absorbed dose of more than 30 Grays.

Vitamin B12 deficiency

Vitamin B12 deficiency may cause, among several neurological abnormalities, overlapping cerebellar and sensory ataxia.

Hypothyroidism

Symptoms of neurological dysfunction may be the presenting feature in some patients with hypothyroidism. These include reversible cerebellar ataxia, dementia, peripheral neuropathy, psychosis and coma. Most of the neurological complications improve completely after thyroid hormone replacement therapy.[15][16]

Causes of isolated sensory ataxia

Peripheral neuropathies may cause generalised or localised sensory ataxia (e.g. a limb only) depending on the extent of the neuropathic involvement. Spinal disorders of various types may cause sensory ataxia from the lesioned level below, when they involve the dorsal columns[17][18][19]

Non-hereditary cerebellar degeneration

Non-hereditary causes of cerebellar degeneration include chronic ethanol abuse, head injury, paraneoplastic and non-paraneoplastic autoimmune ataxia,[20][21][22] high altitude cerebral oedema, coeliac disease, normal pressure hydrocephalus and infectious or post-infectious cerebellitis.

Hereditary ataxias

Ataxia may depend on hereditary disorders consisting of degeneration of the cerebellum and/or of the spine; most cases feature both to some extent, and therefore present with overlapping cerebellar and sensory ataxia, even though one is often more evident than the other. Hereditary disorders causing ataxia include autosomal dominant ones such as spinocerebellar ataxia, episodic ataxia, and dentatorubropallidoluysian atrophy, as well as autosomal recessive disorders such as Friedreich's ataxia (sensory and cerebellar, with the former predominating) and Niemann Pick disease, ataxia-telangiectasia (sensory and cerebellar, with the latter predominating), and abetalipoproteinaemia. An example of X-linked ataxic condition is the rare fragile X-associated tremor/ataxia syndrome.

Arnold-Chiari malformation (congenital ataxia)

Arnold-Chiari malformation is a malformation of the brain. It consists of a downward displacement of the cerebellar tonsils and the medulla through the foramen magnum, sometimes causing hydrocephalus as a result of obstruction of cerebrospinal fluid outflow.

Succinic Semialdehyde Dehydrogenase Deficiency

Succinic semialdehyde dehydrogenase deficiency is an autosomal-recessive gene disorder where mutations in the ALDH5A1 gene results in the accumulation of gamma-Hydroxybutyric acid (GHB) in the body. GHB accumulates in the nervous system and can cause ataxia as well as other neurological dysfunction.[23]

Wilson's disease

Wilson's disease is an autosomal-recessive gene disorder whereby an alteration of the ATP7B gene results in an inability to properly excrete copper from the body.[24] Copper accumulates in the nervous system and liver and can cause ataxia as well as other neurological and organ impairments.[25]

Gluten ataxia

Gluten ataxia is a gluten-related disorder, a wide spectrum of disorders marked by an abnormal immunological response to gluten. Like celiac disease, it is an autoimmune disease.[26] With gluten ataxia, damage takes place in the cerebellum, the balance center of the brain that controls coordination and complex movements like walking, speaking and swallowing.[27] Gluten ataxia is the single most common cause of sporadic idiopathic ataxia.[28]

Gluten ataxia is an immune-mediated disease triggered by the ingestion of gluten in genetically susceptible individuals. It should be considered in the differential diagnosis of all patients with idiopathic sporadic ataxia. Early diagnosis and treatment with a gluten free diet can improve ataxia and prevent its progression. Readily available and sensitive markers of gluten ataxia include anti-gliadin antibodies. Immunoglobulin A (IgA) deposits against transglutaminase 2 (TG2) in the small bowel and at extraintestinal sites are proving to be additionally reliable and perhaps more specific markers of the whole spectrum of gluten sensitivity. They may also hold the key to its pathogenesis.[29]

Gluten ataxia is defined as sporadic cerebellar ataxia associated with the presence circulating antigliadin antibodies and in the absence of an alternative cause for ataxia.[30]

Sodium-potassium pump

Malfunction of the sodium-potassium pump may be a factor in some ataxias. The Na+
-K+
 pump has been shown to control and set the intrinsic activity mode of cerebellar Purkinje neurons.[31] This suggests that the pump might not simply be a homeostatic, "housekeeping" molecule for ionic gradients; but could be a computational element in the cerebellum and the brain.[32] Indeed, an ouabain block of Na+
-K+
 pumps in the cerebellum of a live mouse results in it displaying ataxia and dystonia.[33] Ataxia is observed for lower ouabain concentrations, dystonia is observed at higher ouabain concentrations.

Cerebellar ataxia associated with anti-GAD antibodies

Antibodies against the enzyme glutamic acid decarboxylase (GAD: enzyme changing glutamate in GABA) cause cerebellar deficits.[34] The antibodies impair motor learning and cause behavioral deficits.[35]

Treatment

The treatment of ataxia and its effectiveness depend on the underlying cause. Treatment may limit or reduce the effects of ataxia, but it is unlikely to eliminate them entirely. Recovery tends to be better in individuals with a single focal injury (such as stroke or a benign tumour), compared to those who have a neurological degenerative condition.[36] A review of the management of degenerative ataxia was published in 2009.[37] A small number of rare conditions presenting with prominent cerebellar ataxia are amenable to specific treatment and recognition of these disorders is critical. Diseases include vitamin E deficiency, abetalipoproteinemia, cerebrotendinous xanthomatosis, Niemann–Pick type C disease, Refsum's disease, glucose transporter type 1 deficiency, episodic ataxia type 2, gluten ataxia, glutamic acid decarboxylase ataxia.[38]

The movement disorders associated with ataxia can be managed by pharmacological treatments and through physical therapy and occupational therapy to reduce disability.[39] Some drug treatments that have been used to control ataxia include: 5-hydroxytryptophan (5-HTP), idebenone, amantadine, physostigmine, L-carnitine or derivatives, trimethoprim/sulfamethoxazole, vigabatrin, phosphatidylcholine, acetazolamide, 4-aminopyridine, buspirone, and a combination of coenzyme Q10 and vitamin E.[37]

Physical therapy requires a focus on adapting activity and facilitating motor learning for retraining specific functional motor patterns.[40] A recent systematic review suggested that physical therapy is effective, but there is only moderate evidence to support this conclusion.[41] The most commonly used physical therapy interventions for cerebellar ataxia are vestibular habituation, Frenkel exercises, proprioceptive neuromuscular facilitation (PNF), and balance training; however, therapy is often highly individualized and gait and coordination training are large components of therapy.

Current research suggests that, if a person is able to walk with or without a mobility aid, physical therapy should include an exercise program addressing five components: static balance, dynamic balance, trunk-limb coordination, stairs, and contracture prevention. Once the physical therapist determines that the individual is able to safely perform parts of the program independently, it is important that the individual be prescribed and regularly engage in a supplementary home exercise program that incorporates these components to further improve long term outcomes. These outcomes include balance tasks, gait, and individual activities of daily living. While the improvements are attributed primarily to changes in the brain and not just the hip and/or ankle joints, it is still unknown whether the improvements are due to adaptations in the cerebellum or compensation by other areas of the brain.[40]

Decomposition, simplification, or slowing of multijoint movement may also be an effective strategy that therapists may use to improve function in patients with ataxia.[42] Training likely needs to be intense and focused—as indicated by one study performed with stroke patients experiencing limb ataxia who underwent intensive upper limb retraining.[43] Their therapy consisted of constraint-induced movement therapy which resulted in improvements of their arm function.[43] Treatment should likely include strategies to manage difficulties with everyday activities such as walking. Gait aids (such as a cane or walker) can be provided to decrease the risk of falls associated with impairment of balance or poor coordination. Severe ataxia may eventually lead to the need for a wheelchair. To obtain better results, possible coexisting motor deficits need to be addressed in addition to those induced by ataxia. For example, muscle weakness and decreased endurance could lead to increasing fatigue and poorer movement patterns.

There are several assessment tools available to therapists and health care professionals working with patients with ataxia. The International Cooperative Ataxia Rating Scale (ICARS) is one of the most widely used and has been proven to have very high reliability and validity.[44] Other tools that assess motor function, balance and coordination are also highly valuable to help the therapist track the progress of their patient, as well as to quantify the patient's functionality. These tests include, but are not limited to:

Other uses

The term "ataxia" is sometimes used in a broader sense to indicate lack of coordination in some physiological process. Examples include optic ataxia (lack of coordination between visual inputs and hand movements, resulting in inability to reach and grab objects) and ataxic respiration (lack of coordination in respiratory movements, usually due to dysfunction of the respiratory centres in the medulla oblongata). Optic ataxia may be caused by lesions to the posterior parietal cortex, which is responsible for combining and expressing positional information and relating it to movement. Outputs of the posterior parietal cortex include the spinal cord, brain stem motor pathways, pre-motor and pre-frontal cortex, basal ganglia and the cerebellum. Some neurons in the posterior parietal cortex are modulated by intention. Optic ataxia is usually part of Balint's syndrome, but can be seen in isolation with injuries to the superior parietal lobule, as it represents a disconnection between visual-association cortex and the frontal premotor and motor cortex.[48]

See also

References

  1. ↑ dystaxia. (n.d.). The American Heritage Stedman's Medical Dictionary. Retrieved 09 March 2014, from Dictionary.com website: http://dictionary.reference.com/browse/dystaxia
  2. 1 2 3 4 5 6 7 Schmahmann JD (2004). "Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome". J Neuropsychiatry Clin Neurosci. 16 (3): 367–78. PMID 15377747. doi:10.1176/appi.neuropsych.16.3.367 Freely accessible.
  3. ↑ Fredericks CM (1996). "Disorders of the Cerebellum and Its Connections". In Saladin LK, Fredericks CM. Pathophysiology of the motor systems: principles and clinical presentations (PDF). Philadelphia: F.A. Davis. ISBN 0-8036-0093-3.
  4. ↑ Manto, M.; Godaux, E.; Jacquy, J. (January 1994). "Cerebellar hypermetria is larger when the inertial load is artificially increased". Annals of Neurology. 35 (1): 45–52. ISSN 0364-5134. PMID 8285591. doi:10.1002/ana.410350108.
  5. ↑ Bastian AJ, Zackowski KM, Thach WT (May 2000). "Cerebellar ataxia: torque deficiency or torque mismatch between joints?". J. Neurophysiol. 83 (5): 3019–30. PMID 10805697.
  6. 1 2 Blumenfeld H (2002). Neuroanatomy through clinical cases. Sunderland, Mass: Sinauer. pp. 670–671. ISBN 0-87893-060-4.
  7. ↑ Fonteyn EM, Schmitz-Hübsch T, Verstappen CC, Baliko L, Bloem BR, Boesch S, Bunn L, Charles P, Dürr A, Filla A, Giunti P, Globas C, Klockgether T, Melegh B, Pandolfo M, De Rosa A, Schöls L, Timmann D, Munneke M, Kremer BP, van de Warrenburg BP (June 2010). "Falls in spinocerebellar ataxias: Results of the EuroSCA Fall Study". Cerebellum. 9 (2): 232–9. PMID 20157791. doi:10.1007/s12311-010-0155-z.
  8. ↑ van de Warrenburg BP, Steijns JA, Munneke M, Kremer BP, Bloem BR (April 2005). "Falls in degenerative cerebellar ataxias". Mov. Disord. 20 (4): 497–500. PMID 15645525. doi:10.1002/mds.20375.
  9. 1 2 3 Schmitz TJ, O'Sullivan SB (2007). "Examination of Coordination". Physical rehabilitation. Philadelphia: F.A. Davis. pp. 193–225. ISBN 0-8036-1247-8.
  10. ↑ Manto, Mario; Mariën, Peter (2015). "Schmahmann's syndrome - identification of the third cornerstone of clinical ataxiology". Cerebellum & Ataxias. 2: 2. ISSN 2053-8871. PMC 4552302 Freely accessible. PMID 26331045. doi:10.1186/s40673-015-0023-1.
  11. ↑ "Inadvertent Ingestion of Marijuana --- Los Angeles, California, 2009". Retrieved 3 September 2009.
  12. ↑ Browne TR (May 1976). "Clonazepam. A review of a new anticonvulsant drug". Arch. Neurol. 33 (5): 326–32. PMID 817697. doi:10.1001/archneur.1976.00500050012003.
  13. ↑ Gaudreault P, Guay J, Thivierge RL, Verdy I (1991). "Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment". Drug Saf. 6 (4): 247–65. PMID 1888441. doi:10.2165/00002018-199106040-00003.
  14. ↑ Díez S (2009). "Human health effects of methylmercury exposure". Rev Environ Contam Toxicol. Reviews of Environmental Contamination and Toxicology. 198: 111–32. ISBN 978-0-387-09646-9. PMID 19253038. doi:10.1007/978-0-387-09647-6_3.
  15. ↑ Victor M, Ropper AH, Adams RD, Samuels M (2009). Adams and Victor's Principles of Neurology (Ninth ed.). McGraw-Hill Medical. pp. 78–88. ISBN 0-07-149992-X.
  16. ↑ Pavan MR, Deepak M, Basavaprabhu A, Gupta A (2012). "Doctor i am swaying – An interesting case of ataxia". Journal of Clinical and Diagnostic Research. Retrieved 2 May 2013.
  17. ↑ Spinazzi M, Angelini C, Patrini C (May 2010). "Subacute sensory ataxia and optic neuropathy with thiamine deficiency". Nature Reviews Neurology. 6 (5): 288–93. PMID 20308997. doi:10.1038/nrneurol.2010.16.
  18. ↑ Sghirlanzoni A, Pareyson D, Lauria G (June 2005). "Sensory neuron diseases". Lancet Neurol. 4 (6): 349–61. PMID 15907739. doi:10.1016/S1474-4422(05)70096-X.
  19. ↑ Moeller JJ, Macaulay RJ, Valdmanis PN, Weston LE, Rouleau GA, Dupré N (September 2008). "Autosomal dominant sensory ataxia: a neuroaxonal dystrophy". Acta Neuropathol. 116 (3): 331–6. PMID 18347805. doi:10.1007/s00401-008-0362-6.
  20. ↑ Jarius S, Wildemann B (2015). "'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII". Journal of Neuroinflammation. 12 (1): 166. PMC 4574226 Freely accessible. PMID 26377085. doi:10.1186/s12974-015-0356-y Freely accessible.
  21. ↑ Jarius S, Wildemann B (2015). "'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC". Journal of Neuroinflammation. 12 (1): 167. PMC 4574118 Freely accessible. PMID 26377184. doi:10.1186/s12974-015-0357-x Freely accessible.
  22. ↑ Jarius S, Wildemann B (2015). "'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook". Journal of Neuroinflammation. 12 (1): 168. PMC 4573944 Freely accessible. PMID 26377319. doi:10.1186/s12974-015-0358-9 Freely accessible.
  23. ↑ Pearl, P (2014). "Disorders of GABA metabolism". Journal of Pediatric Epilepsy. 3: 217–227. PMC 4256671 Freely accessible. PMID 25485164. doi:10.3233/PEP-14097.
  24. ↑ Walshe JM. Clarke CE, Nicholl DJ, eds. "Wilson’s Disease" (PDF). Birmingham Movement Disorders Coursebook. Archived from the original (PDF) on 10 September 2011.
  25. ↑ Haldeman-Englert C. "Wilson's disease - PubMed Health". PubMed Health.
  26. ↑ Sapone A, Bai JC, Ciacci C, Dolinsek J, Green PH, Hadjivassiliou M, Kaukinen K, Rostami K, Sanders DS, Schumann M, Ullrich R, Villalta D, Volta U, Catassi C, Fasano A (2012). "Spectrum of gluten-related disorders: consensus on new nomenclature and classification". BMC Medicine (Review). 10: 13. PMC 3292448 Freely accessible. PMID 22313950. doi:10.1186/1741-7015-10-13.
  27. ↑ Boyd C (Feb–Mar 2011). "Gluten Attack: Ataxia A Controversial Call". Living Without.
  28. ↑ Hadjivassiliou M, Grünewald R, Sharrack B, Sanders D, Lobo A, Williamson C, Woodroofe N, Wood N, Davies-Jones A (March 2003). "Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics". Brain. 126 (Pt 3): 685–91. PMID 12566288. doi:10.1093/brain/awg050 Freely accessible.
  29. ↑ Hadjivassiliou M, Sanders DS, Woodroofe N, Williamson C, Grünewald RA (2008). "Gluten ataxia". Cerebellum. 7 (3): 494–8. PMID 18787912. doi:10.1007/s12311-008-0052-x.
  30. ↑ Hadjivassiliou M, Mäki M, Sanders DS, Williamson CA, Grünewald RA, Woodroofe NM, Korponay-Szabó IR (February 2006). "Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia". Neurology. 66 (3): 373–7. PMID 16476935. doi:10.1212/01.wnl.0000196480.55601.3a.
  31. ↑ Forrest MD, Wall MJ, Press DA, Feng J (December 2012). "The Sodium-Potassium Pump Controls the Intrinsic Firing of the Cerebellar Purkinje Neuron". PLoS ONE. 7 (12): e51169. PMC 3527461 Freely accessible. PMID 23284664. doi:10.1371/journal.pone.0051169.
  32. ↑ Forrest MD (December 2014). "The sodium-potassium pump is an information processing element in brain computation". Frontiers in Physiology. 5 (472). doi:10.3389/fphys.2014.00472.
  33. ↑ Calderon DP, Fremont R, Kraenzlin F, Khodakhah K (March 2011). "The neural substrates of rapid-onset Dystonia-Parkinsonism". Nature Neuroscience. 14 (3): 357–65. PMC 3430603 Freely accessible. PMID 21297628. doi:10.1038/nn.2753.
  34. ↑ Mitoma, Hiroshi; Manto, Mario; Hampe, Christiane S. (2017). "Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias". Journal of Immunology Research. 2017: 2913297. ISSN 2314-7156. PMC 5366212 Freely accessible. PMID 28386570. doi:10.1155/2017/2913297.
  35. ↑ Manto, Mario; Honnorat, Jérôme; Hampe, Christiane S.; Guerra-Narbona, Rafael; López-Ramos, Juan Carlos; Delgado-García, José María; Saitow, Fumihito; Suzuki, Hidenori; Yanagawa, Yuchio (2015). "Disease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotransmission and affect motor learning and behavioral functions". Frontiers in Behavioral Neuroscience. 9: 78. ISSN 1662-5153. PMC 4375997 Freely accessible. PMID 25870548. doi:10.3389/fnbeh.2015.00078.
  36. ↑ Morton SM, Bastian AJ (December 2009). "Can rehabilitation help ataxia?". Neurology. 73 (22): 1818–9. PMID 19864635. doi:10.1212/WNL.0b013e3181c33b21.
  37. 1 2 Trujillo-Martín MM, Serrano-Aguilar P, Monton-Alvarez F, Carrillo-Fumero R (June 2009). "Effectiveness and safety of treatments for degenerative ataxias: a systematic review". Mov. Disord. 24 (8): 1111–24. PMID 19412936. doi:10.1002/mds.22564.
  38. ↑ Ramirez-Zamora A, Zeigler W, Desai N, Biller J (Mar 2015). "Treatable causes of cerebellar ataxia". Movement Disorders. 30 (4): 614–623. doi:10.1002/mds.26158.
  39. ↑ Perlman SL (November 2006). "Ataxias". Clin. Geriatr. Med. 22 (4): 859–77, vii. PMID 17000340. doi:10.1016/j.cger.2006.06.011.
  40. 1 2 Ilg W, Synofzik M, Brötz D, Burkard S, Giese MA, Schöls L (December 2009). "Intensive coordinative training improves motor performance in degenerative cerebellar disease". Neurology. 73 (22): 1823–30. PMID 19864636. doi:10.1212/WNL.0b013e3181c33adf.
  41. ↑ Martin CL, Tan D, Bragge P, Bialocerkowski A (January 2009). "Effectiveness of physiotherapy for adults with cerebellar dysfunction: a systematic review". Clinical Rehabilitation. 23 (1): 15–26. PMID 19114434. doi:10.1177/0269215508097853.
  42. ↑ Bastian AJ (June 1997). "Mechanisms of ataxia". Physical Therapy. 77 (6): 672–5. PMID 9184691.
  43. 1 2 Richards L, Senesac C, McGuirk T, Woodbury M, Howland D, Davis S, Patterson T (2008). "Response to intensive upper extremity therapy by individuals with ataxia from stroke". Top Stroke Rehabil. 15 (3): 262–71. PMID 18647730. doi:10.1310/tsr1503-262.
  44. ↑ Schmitz-Hübsch T, Tezenas du Montcel S, Baliko L, Boesch S, Bonato S, Fancellu R, Giunti P, Globas C, Kang JS, Kremer B, Mariotti C, Melegh B, Rakowicz M, Rola R, Romano S, Schöls L, Szymanski S, van de Warrenburg BP, Zdzienicka E, Dürr A, Klockgether T (May 2006). "Reliability and validity of the International Cooperative Ataxia Rating Scale: a study in 156 spinocerebellar ataxia patients". Mov. Disord. 21 (5): 699–704. PMID 16450347. doi:10.1002/mds.20781.
  45. ↑ Schmitz-Hübsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, Giunti P, Globas C, Infante J, Kang JS, Kremer B, Mariotti C, Melegh B, Pandolfo M, Rakowicz M, Ribai P, Rola R, Schöls L, Szymanski S, van de Warrenburg BP, Dürr A, Klockgether T, Fancellu R (June 2006). "Scale for the assessment and rating of ataxia: development of a new clinical scale". Neurology. 66 (11): 1717–20. PMID 16769946. doi:10.1212/01.wnl.0000219042.60538.92.
  46. 1 2 Notermans NC, van Dijk GW, van der Graaf Y, van Gijn J, Wokke JH (January 1994). "Measuring ataxia: quantification based on the standard neurological examination". J. Neurol. Neurosurg. Psychiatr. 57 (1): 22–6. PMC 485035 Freely accessible. PMID 8301300. doi:10.1136/jnnp.57.1.22.
  47. ↑ "OPETA: Neurologic Examination". Online physical exam teaching assistant. The UF College of Medicine Harrell Center. Archived from the original on 18 March 2012. Retrieved 7 May 2012.
  48. ↑ Vallar G (July 2007). "Spatial neglect, Balint-Homes' and Gerstmann's syndrome, and other spatial disorders". CNS Spectr. 12 (7): 527–36. PMID 17603404.

Further reading

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.